Ticker League

Spruce Biosciences (SPRB) Free Cash Flow Bridge

Pinpoint what moved Spruce Biosciences's FCF from TTM through Q1 2025 to TTM through Q1 2026 — operating cash flow shifts and capex changes, each driver sized in dollars.

Analysis
TTM

FCF YoY

+45.39%

OCF YoY

+45.41%

Capex Change

+10.0K

FCF Conversion Δ

Free cash flow bridge for Spruce Biosciences (SPRB) — TTM through Q1 2026 vs TTM through Q1 2025

Δ Free cash flow: $24.4M

FCF bridge breakdown for Spruce Biosciences (SPRB) — TTM through Q1 2026 vs TTM through Q1 2025

  • Prior Free Cash Flow-$53.7M
  • Operating Cash Flow$24.4M
  • Capital Expenditure-$10K
  • Free Cash Outflow-$29.3M
Identity check: drivers reconcile to ΔNI within $0.00
Want to see how cash flow is built up?Cash Flow Waterfall

Frequently asked questions

Data & methodology

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation